CAMBRIDGE, Mass.--(BUSINESS WIRE)--Altus Pharmaceuticals Inc. (NASDAQ: ALTU - News) today announced that Alexey L. Margolin, Ph.D., will retire at the end of 2007 from his position as Senior Vice President, Research and Pre-clinical Development and Chief Scientific Officer. Going forward, Dr. Margolin will continue his relationship with Altus as a scientific advisor.
